Magnésium Bisglycinate + Taurine & Vitamine B6
Food supplement declared in France, declaration No 2024-9-302
Magnésium Bisglycinate + Taurine & Vitamine B6 (nca) is a food supplement declared in France. Status: withdrawn from the market on 4 June 2025. Main ingredients: Magnesium, Vitamin B6, Taurine. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- nca
- Food business operator placing the product on the market
- NCA
- Status
- Withdrawn from the market on 4 June 2025
- Form
- Tablet
- Daily dose
- 2 comprimés par jour
- Directions for use
- Prendre 2 comprimés par jour avec un verre d'eau
- Intended populations
- People over 60, Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Allergy to salicylate derivatives, History of breast cancer, Kidney stones, Congenital G6PD deficiency (favism), Taking away from meals, Children (under 12), Young children (aged 1 to 3), Pregnant women, High blood pressure, Kidney failure, Kidney disease, Infants (under 1 year), Concurrent alcohol consumption, Heart problems, Liver problems, Taking anticoagulants, Taking antidepressants, Taking diabetes medication, Taking blood pressure medication, Taking medication, Taking thyroid medication, Ulcer (stomach or duodenum), Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Nervous system, Mood, Immunity
Declaration 331075, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Taurine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| magnesium bisglycinate | Magnesium | 250 mg | 300 mg |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
Additives
E460, E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ce complément alimentaire ne se substitue pas à un régime alimentaire varié et équilibré, ni à un mode de vie sain. Tenir hors de portée des jeunes enfants. En cas de doute, consultez votre médecin avant utilisation. Ne pas dépasser la dose journalière indiquée. A conserver au sec. Ne doit pas être consommé par les femmes enceintes ou allaitantes et par les enfants de moins de 18 ans. Réservé aux adultes. En cas de traitements médicamenteux, demander conseil à un professionnel de santé.
Regulatory points
- Information
Withdrawn from the market on 4 June 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : nca
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Magnésium Bisglycinate + Taurine & Vitamine B6 (nca): composition and regulation”, https://compoatlas.com/en/supplements/products/331075-magnesium-bisglycinate-taurine-vitamine-b6, updated 15 November 2026.